No Data
No Data
RBC Capital Maintains Sector Perform on Alkermes, Raises Price Target to $40
Earnings Call Summary | Alkermes(ALKS.US) Q1 2025 Earnings Conference
Alks Outlines 2025 Growth With $320M-$340M LYBALVI Sales Target and Key ALKS 2680 Data Milestones
Alkermes Shares Are Trading Higher After the Company Reported Q1 Financial Results and Beat Its EPS and Revenue Estimates.
Alkermes GAAP EPS of $0.13 Beats by $0.08, Revenue of $306.5M Beats by $2.39M
Earnings Scheduled For May 1, 2025
Den the Dragon :


